Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The platform will provide a safe and nurturing space for women, and non-binary individuals
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
Subscribe To Our Newsletter & Stay Updated